| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | - | 1 | - | - | 158 | 81 | 222 | - | - | 463 |
| - | - | - | - | - | 23 | 26 | 23 | - | - | 72 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| 72 | 65 | - | - | 137 |
| 34 | 43 | - | - | 77 |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(R) | 463 | 77.0% | -2.68 | 72 | 48.3% |
| LOP(R) | 137 | 22.8% | -0.83 | 77 | 51.7% |
| Optic-unspecified(R) | 1 | 0.2% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns ME_LOP_unclear | % In | CV |
|---|---|---|---|---|---|
| Tm20 (R) | 35 | ACh | 129 | 21.8% | 0.7 |
| Tm5Y (R) | 19 | ACh | 38 | 6.4% | 0.7 |
| Tm5c (R) | 11 | Glu | 23 | 3.9% | 0.6 |
| Mi16 (R) | 10 | GABA | 23 | 3.9% | 0.5 |
| T4b (R) | 12 | ACh | 22 | 3.7% | 0.8 |
| Cm1 (R) | 8 | ACh | 18 | 3.0% | 0.7 |
| T2a (R) | 13 | ACh | 18 | 3.0% | 0.5 |
| TmY9b (R) | 8 | ACh | 17 | 2.9% | 0.8 |
| Cm5 (R) | 8 | GABA | 16 | 2.7% | 0.7 |
| MeLo3b (R) | 4 | ACh | 15 | 2.5% | 0.7 |
| Dm8a (R) | 3 | Glu | 15 | 2.5% | 0.3 |
| T5b (R) | 11 | ACh | 15 | 2.5% | 0.6 |
| Cm17 (R) | 3 | GABA | 12 | 2.0% | 0.6 |
| Tm29 (R) | 6 | Glu | 12 | 2.0% | 0.4 |
| Pm4 (R) | 5 | GABA | 11 | 1.9% | 0.2 |
| Tm40 (R) | 4 | ACh | 10 | 1.7% | 1.0 |
| LPi12 (R) | 2 | GABA | 10 | 1.7% | 0.4 |
| Cm29 (R) | 3 | GABA | 10 | 1.7% | 0.3 |
| TmY18 (R) | 3 | ACh | 9 | 1.5% | 0.5 |
| Dm2 (R) | 5 | ACh | 9 | 1.5% | 0.5 |
| Y13 (R) | 7 | Glu | 9 | 1.5% | 0.4 |
| Y11 (R) | 5 | Glu | 7 | 1.2% | 0.3 |
| Cm31a (R) | 2 | GABA | 6 | 1.0% | 0.7 |
| Cm19 (R) | 3 | GABA | 6 | 1.0% | 0.7 |
| TmY5a (R) | 5 | Glu | 6 | 1.0% | 0.3 |
| LPC1 (R) | 5 | ACh | 6 | 1.0% | 0.3 |
| Tlp11 (R) | 4 | Glu | 6 | 1.0% | 0.3 |
| Cm2 (R) | 1 | ACh | 5 | 0.8% | 0.0 |
| MeTu4a (R) | 3 | ACh | 5 | 0.8% | 0.6 |
| T5a (R) | 3 | ACh | 4 | 0.7% | 0.4 |
| TmY17 (R) | 3 | ACh | 4 | 0.7% | 0.4 |
| Tm32 (R) | 4 | Glu | 4 | 0.7% | 0.0 |
| Tm37 (R) | 4 | Glu | 4 | 0.7% | 0.0 |
| Cm13 (R) | 4 | Glu | 4 | 0.7% | 0.0 |
| LLPC3 (R) | 1 | ACh | 3 | 0.5% | 0.0 |
| Y3 (R) | 1 | ACh | 3 | 0.5% | 0.0 |
| LPi2c (R) | 1 | Glu | 3 | 0.5% | 0.0 |
| LPT23 (R) | 2 | ACh | 3 | 0.5% | 0.3 |
| Cm10 (R) | 2 | GABA | 3 | 0.5% | 0.3 |
| Tm12 (R) | 2 | ACh | 3 | 0.5% | 0.3 |
| Cm8 (R) | 2 | GABA | 3 | 0.5% | 0.3 |
| Tm30 (R) | 2 | GABA | 3 | 0.5% | 0.3 |
| Cm9 (R) | 3 | Glu | 3 | 0.5% | 0.0 |
| Cm7 (R) | 3 | Glu | 3 | 0.5% | 0.0 |
| Dm8b (R) | 1 | Glu | 2 | 0.3% | 0.0 |
| Cm15 (R) | 1 | GABA | 2 | 0.3% | 0.0 |
| TmY16 (R) | 1 | Glu | 2 | 0.3% | 0.0 |
| OLVC5 (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| LPi2b (R) | 1 | GABA | 2 | 0.3% | 0.0 |
| LPT59 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| 5-HTPMPV03 (L) | 1 | 5-HT | 2 | 0.3% | 0.0 |
| Cm34 (R) | 1 | Glu | 2 | 0.3% | 0.0 |
| MeVC11 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| Mi17 (R) | 2 | GABA | 2 | 0.3% | 0.0 |
| Tm5b (R) | 2 | ACh | 2 | 0.3% | 0.0 |
| Tm33 (R) | 2 | ACh | 2 | 0.3% | 0.0 |
| TmY10 (R) | 2 | ACh | 2 | 0.3% | 0.0 |
| T4a (R) | 2 | ACh | 2 | 0.3% | 0.0 |
| MeTu4c (R) | 2 | ACh | 2 | 0.3% | 0.0 |
| LPi2d (R) | 2 | Glu | 2 | 0.3% | 0.0 |
| OA-ASM1 (R) | 1 | OA | 1 | 0.2% | 0.0 |
| Dm3a (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| Dm3b (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| Tm35 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| Tm5a (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| Cm6 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| Tm1 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| T2 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| TmY4 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| Tm24 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| Cm11a (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| LLPC1 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| LPi3412 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| Y12 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| MeLo14 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| Cm26 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| MeVC21 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| LoVC22 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| OA-AL2i4 (R) | 1 | OA | 1 | 0.2% | 0.0 |
| LPi4b (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| MeVC4b (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| MeVPOL1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| downstream partner | # | NT | conns ME_LOP_unclear | % Out | CV |
|---|---|---|---|---|---|
| Mi17 (R) | 12 | GABA | 39 | 7.6% | 0.5 |
| LLPC1 (R) | 10 | ACh | 37 | 7.2% | 0.8 |
| TmY17 (R) | 12 | ACh | 33 | 6.5% | 0.6 |
| LPi2e (R) | 6 | Glu | 30 | 5.9% | 1.1 |
| Y13 (R) | 9 | Glu | 27 | 5.3% | 1.1 |
| LPLC2 (R) | 10 | ACh | 27 | 5.3% | 0.7 |
| LPT23 (R) | 3 | ACh | 24 | 4.7% | 0.9 |
| TmY16 (R) | 6 | Glu | 20 | 3.9% | 0.7 |
| Cm31b (R) | 1 | GABA | 17 | 3.3% | 0.0 |
| MeVP2 (R) | 3 | ACh | 15 | 2.9% | 0.4 |
| LPi21 (R) | 1 | GABA | 13 | 2.5% | 0.0 |
| LPi2c (R) | 6 | Glu | 10 | 2.0% | 0.7 |
| TmY5a (R) | 7 | Glu | 9 | 1.8% | 0.4 |
| LPLC1 (R) | 2 | ACh | 8 | 1.6% | 0.5 |
| Y14 (R) | 5 | Glu | 8 | 1.6% | 0.5 |
| Tm32 (R) | 5 | Glu | 8 | 1.6% | 0.5 |
| Tm38 (R) | 5 | ACh | 8 | 1.6% | 0.5 |
| Cm13 (R) | 4 | Glu | 7 | 1.4% | 0.7 |
| VS (R) | 1 | ACh | 6 | 1.2% | 0.0 |
| LPC1 (R) | 4 | ACh | 6 | 1.2% | 0.3 |
| MeTu1 (R) | 4 | ACh | 6 | 1.2% | 0.3 |
| MeVP12 (R) | 3 | ACh | 6 | 1.2% | 0.0 |
| LPi43 (R) | 1 | Glu | 5 | 1.0% | 0.0 |
| LPi12 (R) | 2 | GABA | 5 | 1.0% | 0.2 |
| Mi16 (R) | 4 | GABA | 5 | 1.0% | 0.3 |
| MeVP14 (R) | 3 | ACh | 5 | 1.0% | 0.3 |
| LLPC3 (R) | 4 | ACh | 5 | 1.0% | 0.3 |
| Nod2 (R) | 1 | GABA | 4 | 0.8% | 0.0 |
| Am1 (R) | 1 | GABA | 4 | 0.8% | 0.0 |
| T4b (R) | 2 | ACh | 4 | 0.8% | 0.5 |
| Tm40 (R) | 2 | ACh | 4 | 0.8% | 0.5 |
| Tm39 (R) | 2 | ACh | 4 | 0.8% | 0.5 |
| Y3 (R) | 3 | ACh | 4 | 0.8% | 0.4 |
| LLPC2 (R) | 3 | ACh | 4 | 0.8% | 0.4 |
| Cm5 (R) | 4 | GABA | 4 | 0.8% | 0.0 |
| TmY14 (R) | 4 | unc | 4 | 0.8% | 0.0 |
| Cm32 (R) | 1 | GABA | 3 | 0.6% | 0.0 |
| MeVP52 (R) | 1 | ACh | 3 | 0.6% | 0.0 |
| LPi2b (R) | 1 | GABA | 3 | 0.6% | 0.0 |
| Cm4 (R) | 2 | Glu | 3 | 0.6% | 0.3 |
| Cm8 (R) | 2 | GABA | 3 | 0.6% | 0.3 |
| Cm10 (R) | 2 | GABA | 3 | 0.6% | 0.3 |
| Pm4 (R) | 2 | GABA | 3 | 0.6% | 0.3 |
| TmY18 (R) | 3 | ACh | 3 | 0.6% | 0.0 |
| T5b (R) | 3 | ACh | 3 | 0.6% | 0.0 |
| Tm26 (R) | 3 | ACh | 3 | 0.6% | 0.0 |
| Dm8a (R) | 1 | Glu | 2 | 0.4% | 0.0 |
| TmY10 (R) | 1 | ACh | 2 | 0.4% | 0.0 |
| MeTu4a (R) | 1 | ACh | 2 | 0.4% | 0.0 |
| TmY9a (R) | 1 | ACh | 2 | 0.4% | 0.0 |
| MeVP3 (R) | 1 | ACh | 2 | 0.4% | 0.0 |
| MeVP30 (R) | 1 | ACh | 2 | 0.4% | 0.0 |
| MeVP45 (R) | 1 | ACh | 2 | 0.4% | 0.0 |
| H1 (R) | 1 | Glu | 2 | 0.4% | 0.0 |
| LPT50 (R) | 1 | GABA | 2 | 0.4% | 0.0 |
| Cm34 (R) | 1 | Glu | 2 | 0.4% | 0.0 |
| Mi2 (R) | 2 | Glu | 2 | 0.4% | 0.0 |
| T5a (R) | 2 | ACh | 2 | 0.4% | 0.0 |
| Tm37 (R) | 2 | Glu | 2 | 0.4% | 0.0 |
| Tlp13 (R) | 2 | Glu | 2 | 0.4% | 0.0 |
| Tm30 (R) | 2 | GABA | 2 | 0.4% | 0.0 |
| Cm19 (R) | 2 | GABA | 2 | 0.4% | 0.0 |
| VSm (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| T5d (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| Tm33 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| MeTu4b (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| Tm5b (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| MeTu4c (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| TmY20 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| Tm5Y (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| Cm9 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| T2a (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| Cm6 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| Cm7 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| TmY3 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| MeLo3a (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| Cm11a (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| TmY21 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| LPi3412 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| Cm29 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| MeVPMe4 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| LPT49 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| MeVPLo1 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| LPT22 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| Nod1 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| 5-HTPMPV03 (R) | 1 | 5-HT | 1 | 0.2% | 0.0 |